Skip to main content

FDA recall, , Moderate risk

Boston Scientific TheraSphere 360 Y-90 Management Platform

Software anomaly occurs when a user adds one or more vials to the cart and subsequently returns to the Activity Calculator to modify one or more input.

What happened

Boston Scientific Corporation of Maple Grove, Minnesota, recalled its Boston Scientific TheraSphere 360 Y-90 Management Platform, Model Number M00139509001, a Radiological Image Processing System. The recall began June 19, 2026, and was added to the FDA's Enforcement Report on July 22, 2026.

The software anomaly occurs when a user adds one or more vials to the cart and subsequently returns to the Activity Calculator to modify one or more input. When a user modifies an input and selects "Recalculate", the dose calculation is updated correctly; however, any vials that were previously added to the cart are not automatically updated to reflect the revised calculation.

The product was distributed nationwide in the United States, including in states such as Alabama, Arkansas, Arizona, California, Colorado, Florida, Georgia, Illinois, Indiana, Louisiana, Massachusetts, Minnesota, Nebraska, New York, Ohio, Oklahoma, Oregon, South Carolina, South Dakota, Tennessee, Texas, Utah, Washington, Wisconsin, West Virginia and Wyoming. The recall affects 68 units.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

Match the model number and UDI-DI listed under your product.

A UDI-DI is the device identifier printed with the barcode on the device label.

  1. Boston Scientific TheraSphere 360 Y-90 Management Platform

    Model number
    • M00139509001
    UDI-DI
    • 00191506068264

Recall details

Company began the recall
Company
Boston Scientific CorporationMaple Grove, Minnesota
Risk

Moderate risk

Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
99236
Recall number
Z-2771-2026
Quantity recalled
68 units

All recalls from Boston Scientific Corporation

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. Listed on Recall Canary

  4. In FDA's weekly enforcement report

  5. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 2, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)